Bumper Offer - Urjas oil Just @ Rs. 1 X
Recita 5 Tablet is a prescription drug, available for use as Tablet. Primarily, it is used for the treatment of Depression. Other than this, Recita 5 Tablet has some other therapeutic uses, which have been discussed ahead.
Medical history of the patient along with age and gender determines the dosage of Recita 5 Tablet. The condition it has been prescribed for, and the route of administration also determine the right dosage. Refer to the dosage section for a detailed discussion.
While these are the most often observed Recita 5 Tablet side effects, there are can be others also. These have been listed below. Such side effects of Recita 5 Tablet normally do not last long and go away once the treatment is completed. If, however, they worsen or do not go away, please speak with your physician.
Recita 5 Tablet's effect during pregnancy is Moderate and Severe while nursing. Warnings related to Recita 5 Tablet's effects on the liver, heart and kidney, if any, have been listed below.
The section on Recita 5 Tablet contraindications lists all such conditions.
Besides this, Recita 5 Tablet may also have severe interaction with some medicines. See below for a complete list.
Along with the above-mentioned precautions, remember that taking Recita 5 Tablet is considered not safe while driving, and is not addictive.
Recita 5 Tablet is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Adult(Male) |
|
| Geriatric |
|
Based on research, the following side effects have been observed when Recita 5 Tablet is used -
Moderate
Mild
Is the use of Recita 5 Tablet safe for pregnant women?
Recita may have some side effects during pregnancy. Pregnant women should discontinue the use of Recita, and talk to their doctor, if they notice any discomfort.
Is the use of Recita 5 Tablet safe during breastfeeding?
Women who are breastfeeding may experience severe harmful effects after taking Recita. It should only be taken after medical advice.
What is the effect of Recita 5 Tablet on the Kidneys?
Recita has very mild side effects on the kidneys.
What is the effect of Recita 5 Tablet on the Liver?
Recita is rarely harmful for the liver.
What is the effect of Recita 5 Tablet on the Heart?
Recita is rarely harmful for the heart.
Recita 5 Tablet should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Recita 5 Tablet unless your doctor advises you to do so -
Is this Recita 5 Tablet habit forming or addictive?
Recita 5 Tablet is not addictive in nature.
Is it safe to drive or operate heavy machinery when consuming?
After taking Recita 5 Tablet you may feel sleepy. So it is not advised to perform these activities.
Is it safe?
Recita 5 Tablet should be used only after doctor's advice.
Is it able to treat mental disorders?
Yes, this Recita 5 Tablet works for mental disorders.
Interaction between Food and Recita 5 Tablet
Taking Recita 5 Tablet with food does not harm your health.
Interaction between Alcohol and Recita 5 Tablet
Taking Recita 5 Tablet with alcohol can have severely harmful effects on your health.
This medicine data has been created by -
B.Pharma, Pharmacy
7 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Lexapro® (escitalopram oxalate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 461
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 520-522
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Lexapro® (escitalopram oxalate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 461
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 520-522
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Lexapro® (escitalopram oxalate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 461
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 520-522
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Lexapro® (escitalopram oxalate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 461
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 520-522